APA (7th ed.) Citation

Rastogi, A., Pollack, C. V., Lázaro, I. J. S., Lesén, E., Arnold, M., Franzén, S., . . . Kanda, E. (2024). Maintained renin–angiotensin–aldosterone system inhibitor therapy with sodium zirconium cyclosilicate following a hyperkalaemia episode: A multicountry cohort study. Clinical Kidney Journal, 17(5), 1. https://doi.org/10.1093/ckj/sfae083

Chicago Style (17th ed.) Citation

Rastogi, Anjay, et al. "Maintained Renin–angiotensin–aldosterone System Inhibitor Therapy with Sodium Zirconium Cyclosilicate Following a Hyperkalaemia Episode: A Multicountry Cohort Study." Clinical Kidney Journal 17, no. 5 (2024): 1. https://doi.org/10.1093/ckj/sfae083.

MLA (9th ed.) Citation

Rastogi, Anjay, et al. "Maintained Renin–angiotensin–aldosterone System Inhibitor Therapy with Sodium Zirconium Cyclosilicate Following a Hyperkalaemia Episode: A Multicountry Cohort Study." Clinical Kidney Journal, vol. 17, no. 5, 2024, p. 1, https://doi.org/10.1093/ckj/sfae083.